Endocrinology and metabolism 2006: Editorial comments

Current Opinion in Pediatrics

Volumn 18, Issue 4, 2006, Pages 423-426

  Root, Allen W ^a,b  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b JOHNS HOPKINS ALL CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CORTICOTROPIN; FIBRILLIN; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 54; HYDROCORTISONE; KISSPEPTIN; OXIDOREDUCTASE; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANDROGEN SYNTHESIS; ATTENTION DEFICIT DISORDER; CONGENITAL ADRENAL HYPERPLASIA; EDITORIAL; ENZYME DEFECT; HUMAN; MARFAN SYNDROME; METABOLIC DISORDER; PRIORITY JOURNAL; WEIGHT GAIN;

ADRENAL HYPERPLASIA, CONGENITAL; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; DIAGNOSIS, DIFFERENTIAL; ENDOCRINE SYSTEM DISEASES; ENDOCRINOLOGY; HUMANS; MARFAN SYNDROME; TUMOR SUPPRESSOR PROTEINS;

EID: 33747493745     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mop.0000236393.87203.85     Document Type: Editorial

References (9)

1. Karande S. Attention deficit hyperactivity disorder - A review for family physicians. Indian J Med Sci 2005; 59:546-555.
2. Spencer TJ, Newcorn JH, Kratochvil CJ, et al. Effects of atomoxetine on growth after 2- year treatment among pediatric patients with attention deficit/hyperactivity disorder. Pediatrics [online serial] 2005; 116:e74-e80 http://www.pediatrics.org./cgi/doi/10.1542/peds.2004-0624.
3. Donohoue PA. The adrenal gland and its disorders. In: Kappy MS, Allen DB, Geffner ME, editors. Principles and Practice of Pediatric Endocrinology. Springfield, IL: Charles C Thomas; 2005. pp. 357-485.
4. Fukishima M, Hasegawa T, Horikawa R, et al. Cytochrome P450 oxidoreductase deficiency in three patients initially regarded as having 21-hydroxylase deficiency and/or aromatase deficiency: Diagnostic value of urine steroid hormone analysis. Pediatr Res 2006; 59:276-280.
5. Dungan HM, Clifton DK, Steiner RA. Mini-review: Kisspeptin neurons as central processors in the regulation of gonadotropin-releasing hormone secretion. Endocrinology 2006; 147:1154-1158.
6. Van der Berghe G, editor. Endocrinology of critical illness [Special issue including several articles on the endocrinology of critical illness]. Crit Care Clin 2006; 22:1-179.
7. DeGroot LJ. Nonthyroidal illness syndrome is a manifestation of hypothalamic-pituitary dysfunction, and in view of current evidence, should be treated with appropriate replacement therapies. Crit Care Clin 2006; 22:57-86.
8. Judge DP, Dietz HC. Marfan's syndrome. Lancet 2005; 366:1965-1976.
9. Ho NCY, Tran JR, Bektas A. Marfan's syndrome. Lancet 2005; 366:1978-1981.